Vice President, US Market Access Lead - Oncology

Summary    This role serves as the single point of accountability between USMAPPS and the Oncology Business Unit, owning access strategy, payer marketing, and brand-level contracting and pricing strategy across the full oncology portfolio. The role drives and owns outcomes, integrating all USMAPPS capabilities into one coherent access plan that directly supports the Oncology BU President and franchise leads. The Vice President is expected to operate at full strategic weight, lead a team aligned to oncology brands and franchise clusters, and be the single person the Oncology BU holds accountable for market access results.      The Vice President, US Market Access Lead – Oncology reports directly to the Senior Vice President of US Market Access & Pfizer Patient Services (USMAPPS) with a dotted line to the Oncology BU President .  This position requires close partnership with the Oncology BU President, franchise leads, Strategic Contracting & Analytic s , Strategic Account Management, the Patient Services, and USMAPPS leadership. The role sits on the Oncology BU leadership team and on the USMAPPS Leadership Team.

Responsibilities  1. Oncology Access Strategy Ownership   Develop and maintain a fully integrated brand market access plan for all oncology brands, covering payer marketing, contracting strategy, and pricing strategy in one coherent plan   Translate portfolio-level access priorities into brand-specific execution plans, ensuring consistency across franchise teams and alignment with enterprise GTN objectives   Define payer value propositions, messaging, and positioning for Oncology brands in partnership with access marketing resources   Ensure brand-level pricing and contracting strategies optimize net trade sales and gross-to-net outcomes across payer, GPO, and channel   Define and monitor access performance metrics at the brand and portfolio level, including access quality, access speed, GTN performance, and launch readiness   Ensure LOE assets receive efficient, right-sized access support while growth and launch assets receive differentiated, higher-touch engagement models   Periodically reassess and reallocate brand-level resources across the Oncology portfolio based on lifecycle stage, launch timing, and business priority   Proactively adjust access plans in response to external environment shifts, including IRA drug pricing dynamics, 340B evolution, PBM-payer consolidation, and formulary changes     2. BU Partnership & Representation   Serve as the single point of communication and accountability between USMAPPS and the Oncology BU President and franchise leads for all access, contracting strategy, and payer marketing needs   Sit on the Oncology BU leadership team as primary USMAPPS advisor to franchise leads, operating as a strategic partner rather than a transactional interface   Represent Oncology BU access needs back into USMAPPS leadership, escalating resource gaps, strategic misalignment, or unresolved cross-functional tensions   Partner with Oncology BU franchise leads (e.g., Breast Cancer, Prostate Cancer, Hematology) to understand brand P&L objectives and translate these into specific access, contracting, and payer marketing priorities   Flag trade-offs between revenue maximization and GTN discipline to BU and USMAPPS leadership, ensuring enterprise-level decision-making rather than brand-pressure-driven discounting   Proactively socialize USMAPPS access capabilities and strategic intent with Oncology BU leadership to build trust and reduce friction at the interface   Drive a cultural reset within the BU interface toward proactive cross-functional collaboration, strategic ownership mindset, and enterprise-level decision-making     3. Launch Readiness   Own the access chapter of the strategic brand plan for all Oncology pipeline assets, ensuring access strategy is fully integrated into brand planning from early lifecycle stages   Identify and close access